InflaRx N.V. Stock Analysis & AI Score
InflaRx N.V. (IFRX) has an ST Score of 68.5 (B+), driven by its Forecast (A+) and held back by its Growth (B-). Analysts rate it Buy with a $9.00 price target (+484.4% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
AI Daily Briefing
Analysis by AIIFRX Stock Price History
IFRX Technical Indicators
FMPEarnings Surprises
Analyst Forecast
Revenue Mix
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Analyst Price Target
ESG Score
IFRX Latest Stock News
ST Score
InflaRx N.V. (IFRX) has an ST Score of 68.5 (B+), driven by its Forecast (A+) and held back by its Growth (B-). Analysts rate it Buy with a $9.00 price target (+484.4% upside).
- Strongest
- ForecastA+
- Weakest
- GrowthB-
All factor grades
- ForecastA+
- ValuationA
- Financial StrengthA-
- MomentumB+
- ProfitabilityB
- GrowthB-
- Piotroski3/9
Press Releases
Company Contact Details
IFRX stock: frequently asked questions
What is IFRX's ST Score?
InflaRx N.V. (IFRX) has an ST Score of 68.5 (B+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is IFRX a buy, hold, or sell?
Analysts rate IFRX a Buy, with a price target of $9.00 (+484.4% vs the current price). Our ST Score grades it B+ (68.5/100). The ST Score is a data-driven signal, not a recommendation.
What are IFRX's factor grades?
Valuation A, Profitability B, Financial Strength A-, Momentum B+, Growth B-, Forecast A+.
What is IFRX's valuation grade?
InflaRx N.V. (IFRX) earns a valuation grade of A, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is IFRX's growth grade?
InflaRx N.V. (IFRX) earns a growth grade of B-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is IFRX's profitability grade?
InflaRx N.V. (IFRX) earns a profitability grade of B, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is IFRX's financial strength grade?
InflaRx N.V. (IFRX) earns a financial strength grade of A-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for IFRX?
The average analyst price target for InflaRx N.V. (IFRX) is $9.00 from 16 analysts, which is +484.4% versus the recent price of $1.54.
What is IFRX's Piotroski score?
InflaRx N.V. (IFRX) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.